Efficacy and safety of linezolid compared with vancomycin in a randomized, double-blind study of febrile neutropenic patients with cancer.
about
Future challenges and treatment of Staphylococcus aureus bacteremia with emphasis on MRSALinezolid versus vancomycin for skin and soft tissue infectionsLinezolid versus vancomycin for skin and soft tissue infectionsReduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implicationsPharmacokinetic and pharmacodynamic issues for antimicrobial therapy in patients with cancerEfficacy and safety of linezolid in liver transplant patients.Clinical experience of linezolid in bone marrow transplantation patients.Treatment of hospital-acquired pneumonia with linezolid or vancomycin: a systematic review and meta-analysis.Linezolid versus vancomycin for the treatment of suspected methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a systematic review employing meta-analysis.Linezolid versus vancomycin for skin and soft tissue infections.Vancomycin-Induced Thrombocytopenia: A Narrative Review.Vancomycin-associated nephrotoxicity: grave concern or death by character assassination?A pilot study of the efficacy and safety of empiric daptomycin therapy in oncology patients with fever and severe neutropenia.Safety and efficacy of commonly used antimicrobial agents in the treatment of enterococcal infections: a review.The efficacy and safety of linezolid and glycopeptides in the treatment of Staphylococcus aureus infectionsLinezolid for the treatment of drug-resistant infections.Complicated skin and skin-structure infections and catheter-related bloodstream infections: noninferiority of linezolid in a phase 3 study.Invasive gram-positive bacterial infection in cancer patients.The emergence of vancomycin-resistant enterococcal bacteremia in hematopoietic stem cell transplant recipientsDaptomycin for Gram-positive Infections in Patients with Neutropenia: Clinical Experience from a European Outcomes Registry.Clinical update on linezolid in the treatment of Gram-positive bacterial infections.Vancomycin and the Risk of AKI: A Systematic Review and Meta-Analysis.Emerging options for treatment of invasive, multidrug-resistant Staphylococcus aureus infections.Treatment of Staphylococcus aureus infections: new issues, emerging therapies and future directions.Bloodstream infections in neutropenic cancer patients: A practical update.Linezolid: effectiveness and safety for approved and off-label indications.Daptomycin pharmacokinetics in adult oncology patients with neutropenic feverTargeted therapy against multi-resistant bacteria in leukemic and hematopoietic stem cell transplant recipients: guidelines of the 4th European Conference on Infections in Leukemia (ECIL-4, 2011).Linezolid for patients with neutropenia: are bacteriostatic agents appropriate?Management of bacteremia in patients undergoing hematopoietic stem cell transplantation.Emerging drugs in sepsis.Antibiotic management of febrile neutropenia: current developments and future directions.Antimicrobial resistance: Not community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA)! A clinician's guide to community MRSA - its evolving antimicrobial resistance and implications for therapy.Management of gram-positive bacterial infections in patients with cancer.The strategy of antibiotic use in critically ill neutropenic patientsAntimicrobial stewardship in patients with cancer.Linezolid versus vancomycin or teicoplanin for nosocomial pneumonia: meta-analysis of randomised controlled trials.Current research in empirical therapy for febrile neutropenia in cancer patients: what should be necessary and what is going on.Antimicrobial treatment of febrile neutropenia: pharmacokinetic-pharmacodynamic considerations.The prevention and management of infections due to multidrug resistant organisms in haematology patients
P2860
Q22305769-51A15AF8-BF32-46FD-8EB4-9DE8D5E10567Q24186563-019D277E-44BD-414A-99D6-2FF0D2AA5FA0Q24201228-5695714A-0AFE-4A0E-B721-979253631DDEQ24646677-EE35BC68-3555-496B-A0BA-340553BA5FD6Q26825326-24B8329A-14A6-4481-908B-159AD9E786CEQ33394330-102A3EE8-D213-454C-B1BA-2FFD7F2F2209Q33394990-49A7764F-0CC8-4F72-86EC-DD24BC031BC0Q33410942-A3D4B62D-A40E-40B1-9E2A-85B0EF96CEC7Q33418451-A6883C8F-EA08-4757-996C-F33CBBD13A46Q33418740-D195B697-2016-4505-AAC5-398346B03480Q33436796-7AF8C650-EB91-4E67-9513-5816121AFFC3Q33617737-3015F79E-18AC-4ACB-8BC9-D6CE746C612CQ33695234-4E508BF8-372C-4D59-9285-98350A974CE4Q34503844-0DF2DC43-9FCC-4883-9DCE-0C0B463AE6BCQ34618696-A475BC1C-47C5-4D08-84D4-153EDC78152DQ34894133-B94BA527-102F-4DF2-9630-26E105FEB800Q34900607-F62E6D2C-A285-473A-90D8-34A2C7171715Q34999884-215D2B2A-4C1B-4E94-9308-BD1A8D2135C5Q35047852-CE910F89-4B0F-4283-B96D-8CCC7C654479Q36059234-8C6DBD4F-29CB-4347-8DD8-A833EA1F4493Q36083208-1F4205B1-B541-45A5-A45B-620075B33DF3Q36206165-DDBE874B-3210-4F04-BF70-157F34FCADA6Q36718474-BBBAD4AC-2A74-4B08-9DFD-727D810CFBC2Q36758570-06B1A72E-D326-4A08-AB77-002055DDB692Q36913345-94163A6D-86F2-4D18-9C16-A6FA9C817740Q36967288-456B1C55-DCA5-4808-8A67-51F5CF441759Q37072100-6D6BAF55-8E20-460E-B552-C8F1166A275AQ37377897-658A6FFD-2D26-4E19-8A12-2FA1E61C01F5Q37463209-6E2AF883-393C-4C04-BEB2-160E2331EB9EQ37503363-BD52B83F-A1FB-4F26-9FC1-EE812EE9015FQ37670186-D976B315-4F46-4F95-89F1-454319EA76C7Q37708866-0D601721-5C58-48C0-926C-BA006428E822Q37819539-D6825C22-3F95-49A1-8A84-B04F268F1CEDQ37899198-69665F96-A92D-4755-A17A-4E67B1A6F2B0Q37929895-AE0FFF60-8D2F-4F8B-929B-13F58D019D28Q38073198-96E72AF1-EA81-4398-B888-79DF7C0217D6Q38097374-53B61C1C-1816-417D-9EF3-02EF2A7A7113Q38115356-24EBDB46-D6FC-46DE-89F2-D579EE775948Q38117578-276F4744-AC0F-4601-B036-FF50268DD959Q38171538-D7C25320-5890-4E66-9401-AA36197D1CF5
P2860
Efficacy and safety of linezolid compared with vancomycin in a randomized, double-blind study of febrile neutropenic patients with cancer.
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Efficacy and safety of linezol ...... tropenic patients with cancer.
@ast
Efficacy and safety of linezol ...... tropenic patients with cancer.
@en
Efficacy and safety of linezol ...... tropenic patients with cancer.
@nl
type
label
Efficacy and safety of linezol ...... tropenic patients with cancer.
@ast
Efficacy and safety of linezol ...... tropenic patients with cancer.
@en
Efficacy and safety of linezol ...... tropenic patients with cancer.
@nl
prefLabel
Efficacy and safety of linezol ...... tropenic patients with cancer.
@ast
Efficacy and safety of linezol ...... tropenic patients with cancer.
@en
Efficacy and safety of linezol ...... tropenic patients with cancer.
@nl
P2093
P2860
P356
P1476
Efficacy and safety of linezol ...... tropenic patients with cancer.
@en
P2093
Branimir Jaksic
Charlotte S Hartman
Jaime Perez-Oteyza
Kenneth J Tack
Linda B Leonard
P2860
P304
P356
10.1086/500139
P407
P577
2006-01-25T00:00:00Z